Delivery Order SPE2DB22D1002-SPE2DB25FLBT4
Award Date
5/5/25
Potential Completion Date
5/6/25
Potential Value
$1.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of 4559491180 - Imatinib Mesylate 400 mg tablets in 30-count packages. The contract has a ceiling value of $2,099.53 and is a firm-fixed-price delivery order. The award date was January 3, 2023, with an ultimate completion date of January 4, 2023. This delivery order is issued under a larger Indefinite...
Amerisourcebergen Drug Corp has received a firm fixed price delivery order valued at one thousand nine hundred fourteen dollars and twenty-five cents ($1,914.25) from the Defense Logistics Agency (DLA) Troop Support Medical program. As the prime contractor, Amerisourcebergen will supply one hundred (100) tablets of Imatinib Mesylate at one hundred (100) milligrams per tablet to the DLA, with performance taking place at its headquarters in Conshohocken, Pennsylvania. The delivery order was...
The Defense Logistics Agency awarded a $62,130 delivery order to Amerisourcebergen Drug Corporation for Imatinib Mesylate 100mg tablets. Under this firm fixed price contract, Amerisourcebergen will provide 90 tablets of the generic cancer drug to an address in Conshohocken, Pennsylvania by June 28, 2023. As a major supplier of pharmaceuticals to the Department of Defense, Amerisourcebergen frequently receives delivery orders under the DLA's Prime Vendor program to support the medical readiness...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to supply the drug Imbruvica 280 mg tablet for 28-count bottles. The contract has a firm fixed price of $15,151.52 and a completion date of December 12, 2024. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical, which covers a wide range of...
This is a $7,322.67 delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office Division. The order is for the pharmaceutical product Imbruvica 280 mg Tablet, 28s, and has a firm-fixed price. The contract has an ultimate completion date of October 21, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded numerous federal contracts and indefinite delivery contracts (IDCs) by the DLA and other agencies to provide a...
This is a $7,322.67 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Medical Supply Chain to Amerisourcebergen Drug Corporation's Corporate Office Division. The order is for 4,564,522,930 units of the pharmaceutical product IMBRUVICA 420 MG Tablet 28S. The contract has a completion date of May 29, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to...
This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of IBRANCE 100 MG TABLET 7S. The contract has a firm fixed price and a ceiling value of $7,796.30, with a period of performance through May 29, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $16,233.76, is for the delivery of Imbruvica 140mg medication. The contract is a firm fixed-price, non-set-aside award with a performance period through May 27, 2025. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract, valued at $7,322.67, is for the delivery of IMBRUVICA 420 MG tablets to support military treatment programs and facilities. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, with a...
This contract award to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, is a $7,322.67 firm-fixed-price delivery order issued by the Defense Logistics Agency (DLA) to supply the medication Imbruvica 280 mg tablets. The contract has an ultimate completion date of October 21, 2024. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with DLA and other federal agencies, valued up to $999,999,999, to provide a wide range of pharmaceutical and medical...